Cargando…
Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease
The emergence of new and resistant viruses is a serious global burden. Conventional antiviral therapy with small molecules has led to the development of resistant mutants. In the case of hand, foot and mouth disease (HFMD), the absence of a US-FDA approved vaccine calls for urgent need to develop an...
Autores principales: | Lalani, Salima, Gew, Lai Ti, Poh, Chit Laa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648656/ https://www.ncbi.nlm.nih.gov/pubmed/33171280 http://dx.doi.org/10.1016/j.peptides.2020.170443 |
Ejemplares similares
-
Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020) -
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2021) -
Correction: Lalani, S. and Poh, C.L. Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71). Viruses 2020, 12, 184
por: Lalani, Salima, et al.
Publicado: (2020) -
Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71)
por: Masomian, Malihe, et al.
Publicado: (2021) -
Antiviral activity of silymarin in comparison with baicalein against EV-A71
por: Lalani, Salima S., et al.
Publicado: (2020)